{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:28:30Z","timestamp":1793381310529,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T00:00:00Z","timestamp":1536278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T00:00:00Z","timestamp":1536278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recessive dystrophic epidermolysis bullosa (RDEB) patients suffer from chronic and repeatedly infected wounds predisposing them to the development of aggressive and life-threatening skin cancer in these areas. Vitamin D3 is an often neglected but critical factor for wound healing. Intact skin possesses the entire enzymatic machinery required to produce active 1-alpha,25-dihydroxyvitamin D3 (calcitriol), underscoring its significance to proper skin function. Injury enhances calcitriol production, inducing the expression of calcitriol target genes including the antimicrobial peptide cathelicidin (hCAP18), an essential component of the innate immune system and an important wound healing factor. We found significantly reduced hCAP18 expression in a subset of RDEB keratinocytes which could be restored by calcipotriol treatment. Reduced scratch closure in RDEB cell monolayers was enhanced up to 2-fold by calcipotriol treatment, and the secretome of calcipotriol-treated cells additionally showed increased antimicrobial activity. Calcipotriol exhibited anti-neoplastic effects, suppressing the clonogenicity and proliferation of RDEB tumor cells. The combined wound healing, anti-microbial, and anti-neoplastic effects indicate that calcipotriol may represent a vital therapeutic option for RDEB patients which we could demonstrate in a single-patient observation study.<\/jats:p>","DOI":"10.1038\/s41598-018-31823-6","type":"journal-article","created":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T11:27:53Z","timestamp":1535974073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Low-dose calcipotriol can elicit wound closure, anti-microbial, and anti-neoplastic effects in epidermolysis bullosa keratinocytes"],"prefix":"10.1038","volume":"8","author":[{"given":"Christina","family":"Guttmann-Gruber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Tockner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Scharler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"H\u00fcttner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3280-7365","authenticated-orcid":false,"given":"John E.","family":"Common","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeline S. L.","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon L. I. J.","family":"Denil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Klausegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Trost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Breitenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schnitzhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hofbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wolkersdorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Diem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Laimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1810-867X","authenticated-orcid":false,"given":"Dirk","family":"Strunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann W.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4358-7011","authenticated-orcid":false,"given":"Julia","family":"Reichelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina","family":"Pi\u00f1\u00f3n Hofbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,7]]},"reference":[{"key":"31823_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-12","volume":"5","author":"JD Fine","year":"2010","unstructured":"Fine, J. D. Inherited epidermolysis bullosa. Orphanet J Rare Dis 5, 12, https:\/\/doi.org\/10.1186\/1750-1172-5-12 (2010).","journal-title":"Orphanet J Rare Dis"},{"key":"31823_CR2","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/1523-1747.ep12365129","volume":"101","author":"RE Burgeson","year":"1993","unstructured":"Burgeson, R. E. Type VII collagen, anchoring fibrils, and epidermolysis bullosa. J Invest Dermatol 101, 252\u2013255 (1993).","journal-title":"J Invest Dermatol"},{"key":"31823_CR3","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.ajpath.2017.03.003","volume":"187","author":"F Cianfarani","year":"2017","unstructured":"Cianfarani, F., Zambruno, G., Castiglia, D. & Odorisio, T. Pathomechanisms of Altered Wound Healing in Recessive Dystrophic Epidermolysis Bullosa. Am J Pathol 187, 1445\u20131453, https:\/\/doi.org\/10.1016\/j.ajpath.2017.03.003 (2017).","journal-title":"Am J Pathol"},{"key":"31823_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jaad.2008.09.035","volume":"60","author":"JD Fine","year":"2009","unstructured":"Fine, J. D., Johnson, L. B., Weiner, M., Li, K. P. & Suchindran, C. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986\u20132006. J Am Acad Dermatol 60, 203\u2013211, https:\/\/doi.org\/10.1016\/j.jaad.2008.09.035 (2009).","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 1","key":"31823_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1684\/ejd.2015.2552","volume":"25","author":"M Kim","year":"2015","unstructured":"Kim, M. & Murrell, D. F. Update on the pathogenesis of squamous cell carcinoma development in recessive dystrophic epidermolysis bullosa. Eur J Dermatol 25(Suppl 1), 30\u201332, https:\/\/doi.org\/10.1684\/ejd.2015.2552 (2015).","journal-title":"Eur J Dermatol"},{"key":"31823_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6932","volume":"6","author":"E Hoste","year":"2015","unstructured":"Hoste, E. et al. Innate sensing of microbial products promotes wound-induced skin cancer. Nat Commun 6, 5932, https:\/\/doi.org\/10.1038\/ncomms6932 (2015).","journal-title":"Nat Commun"},{"key":"31823_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-9-76","volume":"9","author":"M El Hachem","year":"2014","unstructured":"El Hachem, M. et al. Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa. Orphanet J Rare Dis 9, 76, https:\/\/doi.org\/10.1186\/1750-1172-9-76 (2014).","journal-title":"Orphanet J Rare Dis"},{"key":"31823_CR8","unstructured":"Denyer, J., Pillay, E. & Clapham, J. Best practice guidlines for skin and wound care in epidermolysis bullosa. An International Consensus. Wounds International (2017)."},{"key":"31823_CR9","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/j.1365-2133.2008.08690.x","volume":"159","author":"C Flohr","year":"2008","unstructured":"Flohr, C., Heague, J., Leach, I. & English, J. Topical silver sulfadiazine-induced systemic argyria in a patient with severe generalized dystrophic epidermolysis bullosa. Br J Dermatol 159, 740\u2013741, https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08690.x (2008).","journal-title":"Br J Dermatol"},{"key":"31823_CR10","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1111\/j.1365-2133.2010.09900.x","volume":"163","author":"A Schwieger-Briel","year":"2010","unstructured":"Schwieger-Briel, A. et al. Grey spots in a patient with dystrophic epidermolysis bullosa. Br J Dermatol 163, 1124\u20131126, https:\/\/doi.org\/10.1111\/j.1365-2133.2010.09900.x (2010).","journal-title":"Br J Dermatol"},{"key":"31823_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1529-8019.2012.01493.x","volume":"25","author":"CR Drucker","year":"2012","unstructured":"Drucker, C. R. Update on topical antibiotics in dermatology. Dermatol Ther 25, 6\u201311, https:\/\/doi.org\/10.1111\/j.1529-8019.2012.01493.x (2012).","journal-title":"Dermatol Ther"},{"key":"31823_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.mce.2011.05.017","volume":"347","author":"DD Bikle","year":"2011","unstructured":"Bikle, D. D. Vitamin D metabolism and function in the skin. Mol Cell Endocrinol 347, 80\u201389, https:\/\/doi.org\/10.1016\/j.mce.2011.05.017 (2011).","journal-title":"Mol Cell Endocrinol"},{"key":"31823_CR13","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/jid.2008.380","volume":"129","author":"Y Oda","year":"2009","unstructured":"Oda, Y. et al. Vitamin D receptor and coactivators SRC2 and 3 regulate epidermis-specific sphingolipid production and permeability barrier formation. J Invest Dermatol 129, 1367\u20131378, https:\/\/doi.org\/10.1038\/jid.2008.380 (2009).","journal-title":"J Invest Dermatol"},{"key":"31823_CR14","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1096\/fj.04-3284com","volume":"19","author":"AF Gombart","year":"2005","unstructured":"Gombart, A. F., Borregaard, N. & Koeffler, H. P. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J 19, 1067\u20131077, https:\/\/doi.org\/10.1096\/fj.04-3284com (2005).","journal-title":"FASEB J"},{"key":"31823_CR15","doi-asserted-by":"publisher","unstructured":"Izadpanah, A. & Gallo, R. L. Antimicrobial peptides. J Am Acad Dermatol 52 381\u2013390; quiz 391\u2013382 https:\/\/doi.org\/10.1016\/j.jaad.2004.08.026 (2005).","DOI":"10.1016\/j.jaad.2004.08.026"},{"key":"31823_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1189\/jlb.0403147","volume":"75","author":"MC Zanetti","year":"2004","unstructured":"Zanetti, M. C. multifunctional peptides of the innate immunity. J Leukoc Biol 75, 39\u201348, https:\/\/doi.org\/10.1189\/jlb.0403147 (2004).","journal-title":"J Leukoc Biol"},{"key":"31823_CR17","first-page":"91","volume":"306","author":"MH Braff","year":"2006","unstructured":"Braff, M. H. & Gallo, R. L. Antimicrobial peptides: an essential component of the skin defensive barrier. Curr Top Microbiol Immunol 306, 91\u2013110 (2006).","journal-title":"Curr Top Microbiol Immunol"},{"key":"31823_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.0022-202X.2005.23713.x","volume":"125","author":"B Lopez-Garcia","year":"2005","unstructured":"Lopez-Garcia, B., Lee, P. H., Yamasaki, K. & Gallo, R. L. Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection. J Invest Dermatol 125, 108\u2013115, https:\/\/doi.org\/10.1111\/j.0022-202X.2005.23713.x (2005).","journal-title":"J Invest Dermatol"},{"key":"31823_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/sj.jid.5701043","volume":"128","author":"M Carretero","year":"2008","unstructured":"Carretero, M. et al. In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37. J Invest Dermatol 128, 223\u2013236, https:\/\/doi.org\/10.1038\/sj.jid.5701043 (2008).","journal-title":"J Invest Dermatol"},{"key":"31823_CR20","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1172\/JCI17545","volume":"111","author":"R Koczulla","year":"2003","unstructured":"Koczulla, R. et al. An angiogenic role for the human peptide antibiotic LL-37\/hCAP-18. J Clin Invest 111, 1665\u20131672, https:\/\/doi.org\/10.1172\/JCI17545 (2003).","journal-title":"J Clin Invest"},{"key":"31823_CR21","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jaad.2010.08.028","volume":"65","author":"AL Bruckner","year":"2011","unstructured":"Bruckner, A. L. et al. Correlates of low bone mass in children with generalized forms of epidermolysis bullosa. J Am Acad Dermatol 65, 1001\u20131009, https:\/\/doi.org\/10.1016\/j.jaad.2010.08.028 (2011).","journal-title":"J Am Acad Dermatol"},{"key":"31823_CR22","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jaad.2002.12.002","volume":"50","author":"M Lebwohl","year":"2004","unstructured":"Lebwohl, M., Menter, A., Koo, J. & Feldman, S. R. Combination therapy to treat moderate to severe psoriasis. J Am Acad Dermatol 50, 416\u2013430, https:\/\/doi.org\/10.1016\/j.jaad.2002.12.002 (2004).","journal-title":"J Am Acad Dermatol"},{"key":"31823_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0923-1811(02)00136-6","volume":"31","author":"H Takahashi","year":"2003","unstructured":"Takahashi, H. et al. Similarly potent action of 1,25-dihydroxyvitamin D3 and its analogues, tacalcitol, calcipotriol, and maxacalcitol on normal human keratinocyte proliferation and differentiation. J Dermatol Sci 31, 21\u201328 (2003).","journal-title":"J Dermatol Sci"},{"key":"31823_CR24","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.0022-202X.2004.23443.x","volume":"124","author":"MH Braff","year":"2005","unstructured":"Braff, M. H., Di Nardo, A. & Gallo, R. L. Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies. J Invest Dermatol 124, 394\u2013400, https:\/\/doi.org\/10.1111\/j.0022-202X.2004.23443.x (2005).","journal-title":"J Invest Dermatol"},{"key":"31823_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1525-1470.2009.01070.x","volume":"27","author":"HA Brandling-Bennett","year":"2010","unstructured":"Brandling-Bennett, H. A. & Morel, K. D. Common wound colonizers in patients with epidermolysis bullosa. Pediatr Dermatol 27, 25\u201328, https:\/\/doi.org\/10.1111\/j.1525-1470.2009.01070.x (2010).","journal-title":"Pediatr Dermatol"},{"key":"31823_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1152\/physrev.00014.2015","volume":"96","author":"S Christakos","year":"2016","unstructured":"Christakos, S., Dhawan, P., Verstuyf, A., Verlinden, L. & Carmeliet, G. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol Rev 96, 365\u2013408, https:\/\/doi.org\/10.1152\/physrev.00014.2015 (2016).","journal-title":"Physiol Rev"},{"key":"31823_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1385\/1-59259-869-2:021","volume":"110","author":"A Munshi","year":"2005","unstructured":"Munshi, A., Hobbs, M. & Meyn, R. E. Clonogenic cell survival assay. Methods Mol Med 110, 21\u201328, https:\/\/doi.org\/10.1385\/1-59259-869-2:021 (2005).","journal-title":"Methods Mol Med"},{"key":"31823_CR28","doi-asserted-by":"crossref","unstructured":"Liu, M., Lee, M. H., Cohen, M., Bommakanti, M. & Freedman, L. P. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10, 142-153 (1996).","DOI":"10.1101\/gad.10.2.142"},{"key":"31823_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2657","author":"T Abbas","year":"2009","unstructured":"Abbas, T. & Dutta, A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9, 400-414. https:\/\/doi.org\/10.1038\/nrc2657 (2009).","journal-title":"Nat Rev Cancer 9, 400-414"},{"key":"31823_CR30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.bbrc.2015.10.146","volume":"468","author":"S Chen","year":"2015","unstructured":"Chen, S. et al. 1,25(OH)2D3 attenuates TGF-beta1\/beta2-induced increased migration and invasion via inhibiting epithelial-mesenchymal transition in colon cancer cells. Biochem Biophys Res Commun 468, 130\u2013135, https:\/\/doi.org\/10.1016\/j.bbrc.2015.10.146 (2015).","journal-title":"Biochem Biophys Res Commun"},{"key":"31823_CR31","first-page":"249","volume":"32","author":"N Lopes","year":"2012","unstructured":"Lopes, N. et al. 1Alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast cancer cells by CDH1-promoter demethylation. Anticancer Res 32, 249\u2013257 (2012).","journal-title":"Anticancer Res"},{"key":"31823_CR32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1083\/jcb.200102028","volume":"154","author":"HG Palmer","year":"2001","unstructured":"Palmer, H. G. et al. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 154, 369\u2013387 (2001).","journal-title":"J Cell Biol"},{"key":"31823_CR33","first-page":"3712","volume":"53","author":"M Shabahang","year":"1993","unstructured":"Shabahang, M. et al. 1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res 53, 3712\u20133718 (1993).","journal-title":"Cancer Res"},{"key":"31823_CR34","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/jid.2008.265","volume":"129","author":"JL Charest","year":"2009","unstructured":"Charest, J. L., Jennings, J. M., King, W. P., Kowalczyk, A. P. & Garcia, A. J. Cadherin-mediated cell-cell contact regulates keratinocyte differentiation. J Invest Dermatol 129, 564\u2013572, https:\/\/doi.org\/10.1038\/jid.2008.265 (2009).","journal-title":"J Invest Dermatol"},{"key":"31823_CR35","doi-asserted-by":"publisher","first-page":"550","DOI":"10.12688\/f1000research.6445.1","volume":"4","author":"O Klezovitch","year":"2015","unstructured":"Klezovitch, O. & Vasioukhin, V. Cadherin signaling: keeping cells in touch. F1000Res 4, 550, https:\/\/doi.org\/10.12688\/f1000research.6445.1 (2015).","journal-title":"F1000Res"},{"key":"31823_CR36","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/cncr.27531","volume":"119","author":"Y Ma","year":"2013","unstructured":"Ma, Y. et al. Regulation of motility, invasion, and metastatic potential of squamous cell carcinoma by 1alpha,25-dihydroxycholecalciferol. Cancer 119, 563\u2013574, https:\/\/doi.org\/10.1002\/cncr.27531 (2013).","journal-title":"Cancer"},{"key":"31823_CR37","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1126\/science.1123933","volume":"311","author":"PT Liu","year":"2006","unstructured":"Liu, P. T. et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311, 1770\u20131773, https:\/\/doi.org\/10.1126\/science.1123933 (2006).","journal-title":"Science"},{"key":"31823_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jdermsci.2017.12.009","volume":"90","author":"HD Zomer","year":"2018","unstructured":"Zomer, H. D. & Trentin, A. G. Skin wound healing in humans and mice: Challenges in translational research. J Dermatol Sci 90, 3\u201312, https:\/\/doi.org\/10.1016\/j.jdermsci.2017.12.009 (2018).","journal-title":"J Dermatol Sci"},{"key":"31823_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.04.026","author":"I Fuentes","year":"2018","unstructured":"Fuentes, I. et al. Reduced microbial diversity is a feature of recessive dystrophic epidermolysis bullosa involved skin and wounds. J Invest Dermatol. https:\/\/doi.org\/10.1016\/j.jid.2018.04.026 (2018).","journal-title":"J Invest Dermatol"},{"key":"31823_CR40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ijmm.2013.11.012","volume":"304","author":"MM van der Kooi-Pol","year":"2014","unstructured":"van der Kooi-Pol, M. M., Duipmans, J. C., Jonkman, M. F. & van Dijl, J. M. Host-pathogen interactions in epidermolysis bullosa patients colonized with Staphylococcus aureus. Int J Med Microbiol 304, 195\u2013203, https:\/\/doi.org\/10.1016\/j.ijmm.2013.11.012 (2014).","journal-title":"Int J Med Microbiol"},{"key":"31823_CR41","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.4049\/jimmunol.170.5.2274","volume":"170","author":"A Di Nardo","year":"2003","unstructured":"Di Nardo, A., Vitiello, A. & Gallo, R. L. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol 170, 2274\u20132278 (2003).","journal-title":"J Immunol"},{"key":"31823_CR42","doi-asserted-by":"publisher","first-page":"e3543","DOI":"10.7717\/peerj.3543","volume":"5","author":"M Gardiner","year":"2017","unstructured":"Gardiner, M. et al. A longitudinal study of the diabetic skin and wound microbiome. PeerJ 5, e3543, https:\/\/doi.org\/10.7717\/peerj.3543 (2017).","journal-title":"PeerJ"},{"key":"31823_CR43","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1158\/0008-5472.CAN-16-2929","volume":"77","author":"S Thomas","year":"2017","unstructured":"Thomas, S. et al. The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists. Cancer Res 77, 1783\u20131812, https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2929 (2017).","journal-title":"Cancer Res"},{"key":"31823_CR44","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.ajpath.2014.11.030","volume":"185","author":"SD Kobayashi","year":"2015","unstructured":"Kobayashi, S. D., Malachowa, N. & DeLeo, F. R. Pathogenesis of Staphylococcus aureus abscesses. Am J Pathol 185, 1518\u20131527, https:\/\/doi.org\/10.1016\/j.ajpath.2014.11.030 (2015).","journal-title":"Am J Pathol"},{"key":"31823_CR45","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/path.4118","volume":"229","author":"BS Scales","year":"2013","unstructured":"Scales, B. S. & Huffnagle, G. B. The microbiome in wound repair and tissue fibrosis. The Journal of pathology 229, 323\u2013331, https:\/\/doi.org\/10.1002\/path.4118 (2013).","journal-title":"The Journal of pathology"},{"key":"31823_CR46","doi-asserted-by":"publisher","first-page":"e99029","DOI":"10.1371\/journal.pone.0099029","volume":"9","author":"PE Beaumont","year":"2014","unstructured":"Beaumont, P. E. et al. Cathelicidin host defence peptide augments clearance of pulmonary Pseudomonas aeruginosa infection by its influence on neutrophil function in vivo. PloS one 9, e99029, https:\/\/doi.org\/10.1371\/journal.pone.0099029 (2014).","journal-title":"PloS one"},{"key":"31823_CR47","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.4049\/jimmunol.173.5.2909","volume":"173","author":"TT Wang","year":"2004","unstructured":"Wang, T. T. et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173, 2909\u20132912 (2004).","journal-title":"J Immunol"},{"key":"31823_CR48","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1468-3083.2004.01067.x","volume":"18","author":"S Ingen-Housz-Oro","year":"2004","unstructured":"Ingen-Housz-Oro, S., Blanchet-Bardon, C., Vrillat, M. & Dubertret, L. Vitamin and trace metal levels in recessive dystrophic epidermolysis bullosa. J Eur Acad Dermatol Venereol 18, 649\u2013653, https:\/\/doi.org\/10.1111\/j.1468-3083.2004.01067.x (2004).","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"31823_CR49","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.bone.2011.12.016","volume":"50","author":"B Thuesen","year":"2012","unstructured":"Thuesen, B. et al. Determinants of vitamin D status in a general population of Danish adults. Bone 50, 605\u2013610, https:\/\/doi.org\/10.1016\/j.bone.2011.12.016 (2012).","journal-title":"Bone"},{"key":"31823_CR50","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/wrr.12211","volume":"22","author":"A Gronberg","year":"2014","unstructured":"Gronberg, A., Mahlapuu, M., Stahle, M., Whately-Smith, C. & Rollman, O. Treatment with LL-37 is safe and effective in enhancing healing of hard-to-heal venous leg ulcers: a randomized, placebo-controlled clinical trial. Wound Repair Regen 22, 613\u2013621, https:\/\/doi.org\/10.1111\/wrr.12211 (2014).","journal-title":"Wound Repair Regen"},{"key":"31823_CR51","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1073\/pnas.0900244106","volume":"106","author":"SB Coffelt","year":"2009","unstructured":"Coffelt, S. B. et al. The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells. Proc Natl Acad Sci USA 106, 3806\u20133811, https:\/\/doi.org\/10.1073\/pnas.0900244106 (2009).","journal-title":"Proc Natl Acad Sci USA"},{"key":"31823_CR52","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1158\/1541-7786.MCR-08-0326","volume":"7","author":"SB Coffelt","year":"2009","unstructured":"Coffelt, S. B., Tomchuck, S. L., Zwezdaryk, K. J., Danka, E. S. & Scandurro, A. B. Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells. Mol Cancer Res 7, 907\u2013915, https:\/\/doi.org\/10.1158\/1541-7786.MCR-08-0326 (2009).","journal-title":"Mol Cancer Res"},{"key":"31823_CR53","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/ijc.23186","volume":"122","author":"SB Coffelt","year":"2008","unstructured":"Coffelt, S. B. et al. Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion. Int J Cancer 122, 1030\u20131039, https:\/\/doi.org\/10.1002\/ijc.23186 (2008).","journal-title":"Int J Cancer"},{"key":"31823_CR54","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3233\/CBM-2012-0238","volume":"10","author":"K Gill","year":"2011","unstructured":"Gill, K., Mohanti, B. K., Singh, A. K., Mishra, B. & Dey, S. The over expression of cathelicidin peptide LL37 in head and neck squamous cell carcinoma: the peptide marker for the prognosis of cancer. Cancer Biomark 10, 125\u2013134, https:\/\/doi.org\/10.3233\/CBM-2012-0238 (2011).","journal-title":"Cancer Biomark"},{"key":"31823_CR55","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/pros.21282","volume":"71","author":"JA Hensel","year":"2011","unstructured":"Hensel, J. A. et al. LL-37 as a therapeutic target for late stage prostate cancer. Prostate 71, 659\u2013670, https:\/\/doi.org\/10.1002\/pros.21282 (2011).","journal-title":"Prostate"},{"key":"31823_CR56","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.lungcan.2007.07.014","volume":"59","author":"J von Haussen","year":"2008","unstructured":"von Haussen, J. et al. The host defence peptide LL-37\/hCAP-18 is a growth factor for lung cancer cells. Lung Cancer 59, 12\u201323, https:\/\/doi.org\/10.1016\/j.lungcan.2007.07.014 (2008).","journal-title":"Lung Cancer"},{"key":"31823_CR57","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00005-015-0359-5","volume":"64","author":"E Piktel","year":"2016","unstructured":"Piktel, E. et al. The Role of Cathelicidin LL-37 in Cancer Development. Arch Immunol Ther Exp (Warsz) 64, 33\u201346, https:\/\/doi.org\/10.1007\/s00005-015-0359-5 (2016).","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"31823_CR58","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/exd.12203","volume":"22","author":"C Chamorro","year":"2013","unstructured":"Chamorro, C. et al. Keratinocyte cell lines derived from severe generalized recessive epidermolysis bullosa patients carrying a highly recurrent COL7A1 homozygous mutation: models to assess cell and gene therapies in vitro and in vivo. Exp Dermatol 22, 601\u2013603, https:\/\/doi.org\/10.1111\/exd.12203 (2013).","journal-title":"Exp Dermatol"},{"key":"31823_CR59","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0092-8674(75)90183-X","volume":"6","author":"JG Rheinwald","year":"1975","unstructured":"Rheinwald, J. G. & Green, H. Formation of a keratinizing epithelium in culture by a cloned cell line derived from a teratoma. Cell 6, 317\u2013330 (1975).","journal-title":"Cell"},{"key":"31823_CR60","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics (Oxford, England) 25, 1754\u20131760, https:\/\/doi.org\/10.1093\/bioinformatics\/btp324 (2009).","journal-title":"Bioinformatics (Oxford, England)"},{"key":"31823_CR61","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/nmeth.2066","volume":"9","author":"N Segata","year":"2012","unstructured":"Segata, N. et al. Metagenomic microbial community profiling using unique clade-specific marker genes. Nature methods 9, 811\u2013814, https:\/\/doi.org\/10.1038\/nmeth.2066 (2012).","journal-title":"Nature methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31823-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31823-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31823-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T09:18:58Z","timestamp":1671614338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31823-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,7]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["31823"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-31823-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,7]]},"assertion":[{"value":"27 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13430"}}